Ulcerative colitis treatment
Learn more about the recommended short-, intermediate- and long-term treatment goals in UC and how they can inform therapeutic decisions
Learn more about the recommended short-, intermediate- and long-term treatment goals in UC and how they can inform therapeutic decisions
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Gain expert insights into the place in therapy for current UC treatments and find out how they target key pathways involved in the pathophysiology of ulcerative colitis (UC).
Gain expert insights into the place in therapy for current UC treatments and find out how they target key pathways involved in the pathophysiology of ulcerative colitis (UC).
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Familiarise yourself with the key clinical trial evidence that supported the recent approvals for biologics and targeted small molecules in ulcerative colitis (UC), including concise summaries of their main efficacy and safety findings.
Familiarise yourself with the key clinical trial evidence that supported the recent approvals for biologics and targeted small molecules in ulcerative colitis (UC), including concise summaries of their main efficacy and safety findings.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Although multiple approved treatments are available for UC, clinical remission is still not achieved in a considerable proportion of patients50-52. Learn about the range of investigational treatments that are in phase 3 clinical development for UC to help address this unmet need.
Although multiple approved treatments are available for UC, clinical remission is still not achieved in a considerable proportion of patients50-52. Learn about the range of investigational treatments that are in phase 3 clinical development for UC to help address this unmet need.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Explore our handy summary of clinical guidelines for UC and what aspects of management they address.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
of interest
are looking at
saved
next event
Developed independently by EPG Health who received educational funding from Bristol Myers Squibb in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.